Public sector partner A*STAR is Singapore's leading public sector R&D agency collaborating with government, academia and industry. This presents sales opportunities for scalable research services, contract research, and open-innovation partnerships with national impact.

Industrial collaboration Recent partnerships with Sanofi, GSK, Takeda and Commonwealth Fusion Systems indicate a strong appetite for co-development in biologics, vaccines, advanced materials and fusion energy. Target similarly aligned pharma, biotech, and energy tech firms seeking Asia-Pacific access.

Spin-out potential A*STAR generates commercially viable spin-offs like Mirxes, signaling readiness to partner or acquire early-stage technologies. Sales plays can target licensing, collaboration, or incubation support for emerging biotech and medtech ventures.

Sustainability focus Engagements around environmental standards and sustainability excellence (TR 149:2026) show demand for compliance, green manufacturing, and sustainability benchmarking services. Open opportunities with manufacturers and public bodies pursuing ESG optimization.

Tech-enabled scale A*STAR uses cloud, AI tools and HPC for modeling, simulation and data analytics. This creates upsell opportunities for cloud migrations, AI/ML platforms, data management, and digital research dashboards for large-scale R&D programs.